Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.

about

Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.

Item

http://www.wikidata.org/entity/Q47631015

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cervical cancer screening cote ...... CIN2+ lesions in young women.

@en

Cervical cancer screening cote ...... CIN2+ lesions in young women.

@nl

type

Item

label

Cervical cancer screening cote ...... CIN2+ lesions in young women.

@en

Cervical cancer screening cote ...... CIN2+ lesions in young women.

@nl

prefLabel

Cervical cancer screening cote ...... CIN2+ lesions in young women.

@en

Cervical cancer screening cote ...... CIN2+ lesions in young women.

@nl

P1476

Cervical cancer screening cote ...... f CIN2+ lesions in young women

@en

P2093

Beatriz Calvo

http://www.w3.org/2001/XMLSchema#string

Encarnacion Camarmo

http://www.w3.org/2001/XMLSchema#string

Esther Martin

http://www.w3.org/2001/XMLSchema#string

Francisco Mateos

http://www.w3.org/2001/XMLSchema#string

Hilda Tellez-Safina

http://www.w3.org/2001/XMLSchema#string

Isabel Solis

http://www.w3.org/2001/XMLSchema#string

Jose Antonio Aramburu

http://www.w3.org/2001/XMLSchema#string

Jose Maria Rodriguez-Barbero

http://www.w3.org/2001/XMLSchema#string

Laura Anta

http://www.w3.org/2001/XMLSchema#string

Manuel Zamora

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

A review of the clinical performance of the Aptima HPV assay

Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

HPV screening for cervical cancer in rural India.

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.

Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

P304

1065-1072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DC.23821

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rosario Granados

P577

2017-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28949442

http://www.w3.org/2001/XMLSchema#string